Osaic Holdings’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.65K Sell
1,639
-1,431
-47% -$4.48K ﹤0.01% 6623
2025
Q4
$7.43K Hold
3,070
﹤0.01% 6499
2025
Q3
$5.89K Hold
3,070
﹤0.01% 6663
2025
Q2
$5.74K Sell
3,070
-33
-1% -$57 ﹤0.01% 6470
2025
Q1
$5.52K Buy
3,103
+115
+4% +$300 ﹤0.01% 6119
2024
Q4
$9.44K Buy
2,988
+1,539
+106% +$3.49K ﹤0.01% 5841
2024
Q3
$2.98K Buy
1,449
+1,316
+989% +$2.13K ﹤0.01% 6444
2024
Q2
$193 Sell
133
-66
-33% -$122 ﹤0.01% 7172
2024
Q1
$450 Hold
199
﹤0.01% 6842
2023
Q4
$402 Hold
199
﹤0.01% 6923
2023
Q3
$963 Sell
199
-22
-10% -$128 ﹤0.01% 6838
2023
Q2
$1.46K Buy
221
+22
+11% +$171 ﹤0.01% 6764
2023
Q1
$1.44K Hold
199
﹤0.01% 6845
2022
Q4
$2K Hold
199
﹤0.01% 6728
2022
Q3
$2K Hold
199
﹤0.01% 6857
2022
Q2
$2K Buy
199
+99
+99% +$1.47K ﹤0.01% 6954
2022
Q1
$2K Sell
100
-159
-61% -$3.05K ﹤0.01% 6929
2021
Q4
$6K Hold
259
﹤0.01% 6575
2021
Q3
$8K Buy
259
+79
+44% +$2.41K ﹤0.01% 6346
2021
Q2
$5K Buy
180
+80
+80% +$1.83K ﹤0.01% 6393
2021
Q1
$2K Hold
100
﹤0.01% 6540
2020
Q4
$1K Sell
100
-4
-4% -$86 ﹤0.01% 6294
2020
Q3
$2K Buy
+104
New +$2.19K ﹤0.01% 5908

Other funds holding WHWK

Osaic Holdings's WHWK Position: Q1 2026 in Review

Osaic Holdings reduced its Whitehawk Therapeutics (WHWK) stake by 47% in Q1 2026, selling an estimated $4.48K and leaving 1,639 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #6623.

Osaic Holdings first reported a position in WHWK in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.44K in Q4 2024. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Osaic Holdings held 1,639 shares of Whitehawk Therapeutics worth $5.65K as of Q1 2026.
  • Osaic Holdings sold 1,431 Whitehawk Therapeutics shares in Q1 2026, an estimated $4.48K.
  • Whitehawk Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6623 holding.
  • Osaic Holdings first reported a position in Whitehawk Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Whitehawk Therapeutics position peaked at $9.44K in Q4 2024.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.